Time trends in serum cholesterol before cancer death

Epidemiology

Volumn 8, Issue 2, 1997, Pages 132-136

  Sharp, Stephen John ^a   Pocock, Stuart John ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

cancer; cohort study; data analysis; repeated measurements; serum cholesterol

Indexed keywords

CHOLESTEROL;

ARTICLE; CANCER MORTALITY; CHOLESTEROL BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TIME;

EID: 0031045380     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199703000-00002     Document Type: Article

References (19)

1. McMichael A. Serum cholesterol and human cancer. In: Alfin-Slater R, Kritchevsky D, eds. Human Nutrition: a Comprehensive Treatise. New York: Plenum, 1991;141-158.
2. Isles C, Hole D, Gillis C, Hawthorne V, Lever A. Plasma cholesterol, coronary heart disease and cancer in the Renfrew and Paisley survey. BMJ 1989;298:920-924.
3. Law M, Thompson S, Wald N. Assessing possible hazards of reducing serum cholesterol. BMJ 1994;308:373-379.
4. Law MR, Thompson SG. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 1991; 2:253-261.
5. Simes J. Low cholesterol and risk of non-coronary mortality. Aust N Z J Med 1994;24:113-119.
6. Kreger BE, Anderson KM, Schatzkin A, Splansky GL. Serum cholesterol level, body mass index, and the risk of colon cancer. Cancer 1992;70:1038-1043.
7. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991;303:276-282.
8. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-1060.
9. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-412.
10. Pocock SJ, Seed PT. Cholesterol in elderly women. Lancet 1992;339:1426.
11. Sorlie PD, Feinleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst 1982;69: 989-996.
12. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981;245:247-252.
13. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 1987;257:2176-2180.
14. Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-286.
15. Hughes M, Raskino C, Pocock S, Biagini M, Burroughs A. Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med 1992;11:1-15.
16. Cupples L, D'Agostino R, Anderson K, Kannel W. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 1988;7:205-218.
17. SAS Institute. SAS Technical Report P-229. SAS/STAT Software: Changes and Enhancements. Release 6.07. Cary, NC: SAS Institute, 1992; 287-366.
18. Stata Reference Manual. College Station, TX: Stata Corporation, 1993.
19. Wu M. Time-of-measurement effects in longitudinal studies. J Chron Dis 1980;33:207-213.